EMEA-001930-PIP01-16-M02

Key facts

Active substance
  • Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup C polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup W polysaccharide conjugated to tetanus toxoid (MenACYW)
Therapeutic area
Vaccines
Decision number
P/0169/2019
PIP number
EMEA-001930-PIP01-16-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of Meningococcal disease
Route(s) of administration
Intramuscular use
Contact for public enquiries
Sanofi Pasteur

Tel.  +33 437373055
E-mail: piplan@sanofi.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
View 1 rating
1 rating